Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...
Successful completion of the first large-scale manufacture of narmafotinib which produced approx. 13 kg of drugSuccessful transition of process ...
The market is ripe for growth driven by pharma outsourcing to CDMOs, emphasizing advanced drug products and integrated ...
A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...
Under the agreement, the two companies will jointly undertake co-development of a multi-year pipeline of high-value specialty ...
Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:30 Hrs [IST] ...
Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for ...
With the Union Budget just around the corner, attention is firmly fixed on North Block as India's corporate sector looks for ...
Market corrections often punish expensive stocks, but some hold firm. Mint explains why select high-valuation companies stay ...
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals with a strong presence across Latin America, announces an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results